Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cinemark Holdings Inc
CNK
Consumer Cyclical
Leisure
Cinemark Holdings, Inc. is a movie theatre company. The Company is engaged in the motion picture exhibition industry, with theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. Its circuit, comprised of various brands that also...
include Century, Tinseltown and Rave, operates approximately 497 theaters with 5,653 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as concert, sporting and gaming events, and others.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NYSE:CNK)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
Denver67
X
Post by
Denver67
on Dec 10, 2021 2:18am
FSD Pharma Establishes New Regulatory Advisory Board
FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members Regulatory Advisory Board will oversee the drug development
...more
(0)
•••
Denver67
X
Post by
Denver67
on Dec 06, 2021 10:21pm
H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(0)
•••
Denver67
X
Post by
Denver67
on Dec 03, 2021 11:39pm
FSD Pharma at the H.C. Wainwright 2nd Annual Psychedelics
FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD
...more
(0)
•••
Denver67
X
Post by
Denver67
on Dec 03, 2021 2:52am
FSD Pharma: Demonstrating the Positive Effects of Lucid-MS
FSD Pharma Unveils Videos Demonstrating Positive Effects of
...more
(0)
•••
Denver67
X
Post by
Denver67
on Dec 01, 2021 8:26pm
📰📣iMining Technologies Launches Concierge Service📢📣📣
↓↓↓↓↓↓↓↓↓↓↓↓↓Click the link for the Full Details of the Article: ↓↓↓↓↓↓↓↓↓↓↓↓↓ BitBit Financial Inc., a wholly owned subsidiary of iMining Technologies Inc., has set-up concierge
...more
(0)
•••
Denver67
X
Post by
Denver67
on Nov 26, 2021 11:32pm
🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣
(0)
•••
Denver67
X
Post by
Denver67
on Nov 23, 2021 8:40pm
📰📣Anthony Durkacz on Building a Turnaround at FSD Pharma🎥
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Canadian clean tech company pioneering the upcycling of used motor oil into high value Group III base oils
A Canadian mineral company at the crossroads of electrification and defense
New Analyst Report Lifts Almonty Target Price to CDN$5.50